A Study to Evaluate the Effect of add-on Pioglitazone or Glimepiride in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: SYR-322-4833; Drug: Alogliptin; Drug: Metformin; Drug: Glimepiride Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Glimepiride | Metformin | Research | Study